Refine by
Oncology Drug Services
10 services found
by:CureMatch, Inc. based inSan Diego, CALIFORNIA (USA)
The comprehensive analysis considers commonly used treatments, as well as targeted therapy, immunotherapy, hormone therapy, and newly approved oncology drugs. These options are presented either alone (monotherapy) or in combinations of up to 4 ...
by:Champions Oncology, Inc. based inHackensack, NEW JERSEY (USA)
Champions Oncology's ex vivo AML co-culture platform for Immuno-Oncology therapeutic testing. Champions Oncology has launched an innovative new platform enabling Acute Myeloid Leukemia (AML) researchers the ability to better understand their therapeutic mechanism of action. The Autologous AML Platform is an ex vivo co-culture assay developed and ...
by:Champions Oncology, Inc. based inHackensack, NEW JERSEY (USA)
Champions Oncology's ex vivo 3D co-culture platform for Immuno-Oncology therapeutic testing. Champions Oncology has launched an innovative new platform enabling Immuno-Oncology researchers the ability to test their therapeutics in a 3D organoid assay that can mimic mechanism of action. The Autologous TIL platform is an ex vivo 3D ...
by:Champions Oncology, Inc. based inHackensack, NEW JERSEY (USA)
Champions Oncology is transforming drug discovery and development through our integrated scientific approach. Our expert team works to improve cancer outcomes each day for our research partners and ultimately patients across the ...
by:Natera, Inc. based inAustin, TEXAS (USA)
Why partner with Signatera for your clinical trial? Clinically validated across multiple solid tumors, Signatera has shown to predict relapse in >98% of patients without further treatment. Experienced team with Global reach: CE Mark, three FDA Breakthrough Device Designations, 8 Non-Significant Risk (NSR) determinations. >60 Natera IP assets covering ctDNA MRD and ...
by:Champions Oncology, Inc. based inHackensack, NEW JERSEY (USA)
Champions' Discovery Services leverages the Lumin Analytic Engine and rapid validation workflows to identify novel therapeutic targets and/or biomarkers of ...
by:Revvity Gene Delivery (formerly SIRION Biotech) based inHamburg, GERMANY
In the discovery of oncology therapeutics, Antibody-drug conjugates (ADCs) are rapidly gaining momentum, with hundreds of candidates advancing through clinical development. Whether your priority lies in assessing the epitope binding of your construct, evaluating the cytotoxic potency of the payload, or scrutinizing the efficacy of the linker in cleaving, each ...
by:Oncimmune Holdings PLC based inNottingham, UNITED KINGDOM
Viewing cancer through the immune lens (immuno-oncology) has led to the most promising advancements in cancer treatment in recent history, nonetheless the full potential of the approach is as yet ...
Manufactured by:Piramal Pharma Solutions (PPS) based inMumbai, INDIA
We offer pharmaceutical development services for oral solids, liquids, creams, ointment and sterile injectable from our facilities in US, UK and India. As a leader in integrated solutions, we seamlessly engage our global sites to conduct development work in parallel; accelerating time to market and reduce costs for our ...
Manufactured by:XILIS, Inc. based inDurham, NORTH CAROLINA (USA)
Xilis’ rapid and scalable patient-derived MicroOrganoSphere (MOS) technology platform enhances precision medicine and pharmaceutical drug discovery and development. Compared to conventional patient-derived models, MOS provides faster, higher-throughput, and greater cost savings, as well as more predictive and accurate results. MOS can be used in large-scale pharmacogenomic studies that are ...